NK/T细胞淋巴瘤的检查点免疫疗法——决战时刻到了？
Checkpoint immunotherapy for NK/T cell lymphoma-Time for a showdown?
作者信息
Chan Jason Yongsheng, Lim Jing Quan, Ong Choon Kiat
机构信息
Division of Medical Oncology, National Cancer Centre Singapore, 169610, Singapore.
Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, 169610, Singapore.
出版信息
Precis Clin Med. 2021 Jan 30;4(1):70-72. doi: 10.1093/pcmedi/pbab004. eCollection 2021 Mar.
Abstract
A commentary on "Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma".
摘要
关于“抗PD-1抗体与P-GEMOX联合作为晚期自然杀伤/T细胞淋巴瘤潜在有效免疫化疗方案”的述评
Zotero 插件